CAS Medical Systems

What CAS Medical Systems does

CAS Medical Systems is a U.S.-based medical device company founded in 1984 and headquartered in Branford, Connecticut. The company develops non-invasive technologies and products designed to collect and monitor patient data in critical care environments, addressing the vital parameter monitoring devices market — a segment projected to grow to $12.38 billion by 2030 at a 7.7% CAGR. Its offerings sit within the broader pulse oximeter and hemodynamic monitoring space, where large incumbents such as Edwards Lifesciences and BD (Becton, Dickinson and Company) are actively consolidating, including BD's $4.2 billion acquisition of Edwards Lifesciences' Critical Care business in September 2024.

The company was previously publicly traded on NASDAQ under the ticker CASM and is now delisted. It has raised approximately $28.9 million in disclosed funding across three rounds (2010, 2011, and 2018), with Thomas, McNerney & Partners leading a $15M round in 2011 and Armentum Partners participating in a $12M round in 2018. The company operates with 51-100 employees and is led by Thomas M. Patton (President, CEO, and Director), Paul B. Benni (CSO), and Kimberly Strusky (EVP U.S. Sales). The presence of a dedicated U.S. sales executive suggests a direct sales model targeting hospital and critical care customers domestically.

Critical data gaps limit deeper assessment: no company-specific revenue figures, product details, customer logos, AI/technology stack details, or recent corporate actions are disclosed in the source material. The market context indicates industry-wide tailwinds from remote patient monitoring, telemedicine expansion, and AI integration, but there is no evidence that CAS Medical Systems is positioned to capture these trends. The delisted status, absence of recent funding activity, and lack of disclosed strategic moves since 2018 raise questions about the company's current operational trajectory.

Name

CAS Medical Systems

Website

https://casmed.com

Company type

Private

Founded year

1984

Headcount range

51–100 employees

Short description

CAS Medical Systems is a U.S. medical device company founded in 1984 that develops non-invasive technologies and products to collect and monitor patient data in critical care environments, serving hospital and acute-care customers.

Ownership category

akta.pro rank

Product category

Patient Monitoring Devices

NAICS

Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI)

Keywords

• Non-invasive patient monitoring
• Patient data collection
• Critical care monitoring
• Medical monitoring devices
• Vital sign monitoring

Headquarters

HQ city

Branford

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations

Core offering

CAS Medical Systems develops non-invasive technologies and products that collect and monitor patient data in critical environments. The company operates in the vital parameter monitoring devices and equipment market, serving the demand for remote patient monitoring and hemodynamic/vital sign measurement in clinical settings.

Differentiator

Problem solved

Functional benefit

Products and services

• Non-Invasive Patient Monitoring Products

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered flagship and minor.

• BD (Becton, Dickinson and Company)flagshipStrategic or Co-development Partner · 1 September 2024In September 2024, BD acquired Edwards Lifesciences' Critical Care business for $4.2 billion to strengthen BD's smart connected care portfolio with hemodynamic monitoring technologies. This represents a major strategic acquisition in the vital parameter monitoring space.
• Blue Spark TechnologiesminorOthers · 1 January 2024Blue Spark Technologies launched its VitalTraq multi-vital remote patient monitoring platform in January 2024, exemplifying innovative product trends shaping the vital parameter monitoring sector.

Scale indicators2 records

Recent moves3 records

Expansion highlights2 records

Broad incumbents

• GE HealthCare: GE HealthCare's Patient Care Solutions portfolio includes multi-parameter vital-signs monitors and anesthesia monitoring used in critical care and perioperative environments. As a broad incumbent with strong hospital channel relationships, GE is a primary competitor for CAS Medical's monitoring capital equipment.
• Medtronic: Medtronic's Patient Monitoring business (formerly Covidien) competes broadly in multi-parameter vital-signs monitoring and capnography across hospital and perioperative settings. As a diversified med-tech incumbent, Medtronic offers bundled monitoring solutions that compete against CAS Medical at large hospital systems.
• Philips Patient Monitoring: Philips' Patient Monitoring and Analytics solutions (IntelliVue platform) are widely deployed across ICUs and step-down units globally. Philips competes with CAS Medical in continuous vital-signs and hemodynamic monitoring at large health systems.

Direct peers

• Mindray Bio-Medical Electronics: Mindray is a fast-growing Chinese med-tech company with a broad patient-monitoring and in-vitro diagnostics portfolio that competes aggressively on price in the vital-signs monitor segment. Mindray is increasingly relevant to CAS Medical's market as it expands into U.S. and European hospital accounts.
• Spacelabs Healthcare: Spacelabs Healthcare (subsidiary of OSI Systems) specializes in patient monitoring and diagnostic cardiology for hospitals. Its vital-signs and telemetry offerings place it in direct competition with CAS Medical in the U.S. hospital channel.
• Drägerwerk: Dräger is a leading specialist in anesthesia, ventilation, and critical-care patient monitoring (e.g., Infinity series), with strong penetration in European and emerging markets. Dräger competes directly with CAS Medical in the ICU and perioperative monitoring niche.
• Nonin Medical: Nonin Medical is a private specialist in pulse oximetry and capnography, with both clinical and consumer-grade products. Nonin directly competes with CAS Medical's oximetry offerings, particularly in lower-acuity and home-care settings.
• Masimo: Masimo is a direct competitor in pulse oximetry and non-invasive patient monitoring, including SET® pulse oximetry and rainbow® technology that overlaps directly with CAS Medical's oximetry and vital-signs monitoring products. Both companies compete for the same hospital and perioperative accounts.
• Nihon Kohden: Nihon Kohden is a specialist in patient monitoring, ECG, and neurology, with a global footprint centered on Japan and Asia. Its multi-parameter monitors and EEG/cerebral monitoring overlap with CAS Medical's vital-signs and cerebral oximetry products.
• Edwards Lifesciences Critical Care (now BD): Edwards' Critical Care group (acquired by BD in Sept 2024 for $4.2B) was the leading hemodynamic monitoring franchise, including FORE-SIGHT cerebral oximetry and continuous noninvasive blood pressure — categories that directly overlap CAS Medical's FORE-SIGHT and Max Series offerings.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat3 records

Key risks4 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/cas-medical-systems

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CAS Medical Systems